Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. NASDAQ OMX GlobeNewswire Message Board

Sente, Inc. and Tri-City Medical Center Announce D

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 301275
Posted On: 10/08/2013 11:45:19 AM
Avatar
Posted By: News Desk 2018
Sente, Inc. and Tri-City Medical Center Announce Distribution Agreement

SAN DIEGO, Oct. 8, 2013 (GLOBE NEWSWIRE) -- Senté, Inc., a privately held cosmeceutical company engaged in the development of innovative and targeted medical skincare products based on glycoproteins, today announced that the company has entered into a distribution agreement with Tri-City Medical Center, a Gold Seal-approved, full-service, acute-care hospital. Under this alliance, Tri-City Medical Center will sell and distribute Senté Dermal Repair Cream to patients in the Tri-City Laser and Aesthetic Center adjacent to the Tri-City Wellness Center in Carlsbad.

"Senté's science-based approach to skincare and impressive clinical results are a natural fit for the Tri-City Laser and Aesthetic Center," said David Bennett, Senior Vice President and Chief Marketing Officer for Tri-City Medical Center. "Our physicians, nurses and aestheticians have been very pleased with the results that Senté Dermal Repair Cream has achieved both as a standalone anti-aging regimen and following common facial aesthetic procedures such as laser treatments."

The Tri-City Laser and Aesthetic Center is the first and only state-licensed cosmetic center in California associated with a Joint Commission accredited hospital, Tri-City Medical Center. The center's clients can now purchase the Senté dermal repair cream for use at home following a consultation with the center's medical staff.

"We continue to expand the distribution of Senté Dermal Repair Cream and are excited to be affiliated with Tri-City," said Michael York, President and Chief Executive Officer of Senté, Inc. "Tri-City's team of multidisciplinary physicians, state of the art facilities and focus on the patient is an ideal place for Senté to offer its science-based skincare products to patients."

Senté Dermal Repair Cream is a physician dispensed dermatological product that features a proprietary formulation of the active ingredient heparan sulfate (HS). Senté Dermal Repair Cream helps the body replenish the essential skin building blocks that are lost with aging and UV exposure. Clinical studies demonstrate that Senté Dermal Repair Cream is ideal for use following common dermatological procedures such as IPL, lasers, chemical peels, skin tightening and injectables, due to the skin soothing (lenitive effect) and wound healing properties of heparan sulfate. Senté Dermal Repair Cream can also be used as a skin maintenance therapy following a procedure and for everyday use for treatment of fine lines, hydration, skin tone and texture.

For a comprehensive review of the role of Heparan Sulfate in skin functions see Sarrazin et al., 2011, Cold Spring Harb Perspect Bio doi:10.1101 .

About Senté, Inc.

Senté, Inc. is a privately held cosmeceutical company based in San Diego, California. The company is a recognized leader in the development of innovative and targeted medical skincare products based on glycoproteins. Senté recently launched its first physician dispensed dermatological product, Senté Dermal Repair Cream, which is currently the only cosmeceutical product utilizing heparan sulfate on the market today. Senté is leveraging its expertise in biotechnology to deliver novel products for a variety of dermatological concerns. More information on the company can be found at http://www.sentelabs.com .

About Tri-City Medical Center

Tri-City Medical Center has served its community for more than half a century and is a Gold Seal-approved full service, acute-care hospital with two advanced institutes and physicians practicing in 60 specialties. Tri-City Medical Center has become the county's leader in robotic and minimally invasive surgical technologies, including being the exclusive county-wide provider for the Mazor Renaissance Surgical Guidance System for surgical repair of spinal deformities, injuries and rehabilitation; and the NavioPFS™ system ("Blue Belt") for robotic knee repair, which is less invasive and preserves the existing knee. Tri-City Medical Center also has the only Level III Neonatal Intensive Care Unit in North San Diego County, now with the NICView System, a password-protected webcam system that allows parents and relatives to remotely view their newest family member. Tri-City Medical Center was named by the editors of Becker's Hospital Review both one of the "100 Great Hospitals in America" and one of the "100 Great Places to Work in Healthcare." Selected from over 5,700 hospitals, Tri-City Medical Center was recognized as an innovator in medical treatments, research, technology and care delivery as well as an anchor of health in the country.

For more information about Tri-City Medical Center and Tri-City Healthcare District, please visit www.tricitymed.org

Media Contact: Sente, Inc. Aaron Hasnain T (760) 753-5400



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us